• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER® TORQVUE® (UNKNOWN); CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER® TORQVUE® (UNKNOWN); CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Biocompatibility (2886)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, 20 patients were implanted with an amplatzer cardiac plug and 24 were implanted with an amplatzer amulet.One patient had a tamponade due to the delivery system used.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported through a research article identifying amplatzer cardiac plug and amulet that may be related to complications post procedure.Details are listed in the article, titled "dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the amplatzer cardiac plug" it was reported in the article that 44 patients were implanted with an amplatzer cardiac plug (20) or amulet (24) between february 2011 to october 2016.39 patient were included in the analysis.These patients had an average age of 78, with 20 of them being male.The baseline characteristics include: permanent atrial fibrillation, congestive heart failure, hypertension, diabetes, stroke/tia, vascular disease, and bleeding.A major adverse event observed was one case of tamponade due to left atrial appendage perforation by the delivery system that was treated successfully by pericardiocentesis after device deployment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER® TORQVUE® (UNKNOWN)
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9990479
MDR Text Key188903230
Report Number2135147-2020-00153
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 04/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/31/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-